What is the appropriate prescription regimen for Feramax (ferrous sulfate) in an adult with confirmed iron‑deficiency anemia who has not responded to or cannot tolerate conventional ferrous salts?

Feramax Prescription for Iron-Deficiency Anemia

Critical Clarification

The FDA drug label provided 1 indicates that "Feramax" contains guaifenesin 400 mg (an expectorant), NOT iron—this appears to be a labeling error or product name confusion. For prescribing iron supplementation in adults with confirmed iron-deficiency anemia who have failed or cannot tolerate conventional ferrous salts, the following evidence-based approach applies:

Primary Recommendation

Start with ferrous sulfate 50-100 mg elemental iron once daily (equivalent to one 200 mg ferrous sulfate tablet), taken on an empty stomach, as this is the least expensive and equally effective option compared to other formulations. 2, 3

Dosing Algorithm

First-Line Oral Iron Therapy

• Dose: 50-100 mg elemental iron once daily 3

  • One ferrous sulfate 200 mg tablet = 65 mg elemental iron 3
  • Take in the fasting state for optimal absorption 3

• Frequency: Once daily maximum—hepcidin elevation persists 48 hours after iron ingestion, blocking further absorption with more frequent dosing 2

• Add vitamin C: 500 mg (or 80 mg minimum) with each iron dose to enhance absorption 2

• Avoid: Tea and coffee within 1 hour of iron intake (powerful absorption inhibitors) 2

Alternative Dosing for Intolerance

If gastrointestinal side effects occur with daily dosing, switch to every-other-day dosing (50-100 mg elemental iron) rather than changing iron formulations. 2, 3

• Every-other-day dosing shows similar hemoglobin increases with significantly lower nausea rates 3
• Fractional iron absorption is higher with alternate-day administration 3
• Gastrointestinal adverse events reduced by 44% (RR 0.56) with intermittent dosing 3

Monitoring Protocol

• Week 2: Check hemoglobin—expect ≥10 g/L rise (sensitivity 90.1% for predicting treatment success) 3

  • If hemoglobin rise <10 g/L at 2 weeks, strongly predictive of treatment failure 3

• Every 4 weeks: Monitor hemoglobin until normalized 3

• After normalization: Continue oral iron for 2-3 months to replenish iron stores 3

When Oral Iron Fails

Switch to intravenous iron if the patient does not tolerate oral iron, ferritin levels do not improve after a trial of oral iron, or the patient has conditions preventing oral iron absorption. 2

Indications for IV Iron

• Intolerance to oral iron despite alternate-day dosing 2, 3
• No hemoglobin response after 2 weeks of adequate oral therapy 3
• Malabsorption conditions (inflammatory bowel disease with active inflammation, post-bariatric surgery, celiac disease) 2
• Ongoing blood loss unresponsive to oral therapy 3

IV Iron Selection

Prefer formulations requiring 1-2 infusions over those requiring multiple doses (ferric carboxymaltose or ferric derisomaltose preferred over iron sucrose). 2

Common Pitfalls

• Do NOT switch between different ferrous salts (ferrous sulfate, fumarate, gluconate)—no evidence supports superiority of one over another, and switching does not improve tolerance 2, 3

• Do NOT prescribe modified-release preparations—they are less suitable and more expensive without proven benefit 3

• Do NOT dose iron more than once daily unless using alternate-day regimen—this increases side effects without improving absorption due to hepcidin elevation 2

• Do NOT use ferric maltol as first-line—reserve for patients with inflammatory bowel disease who have failed traditional iron salts; it is significantly more expensive (£47.60 vs £1.00 per 28 days) 3

Cost Considerations

• Ferrous sulfate 200 mg: £1.00 per 28 days 3
• Ferric maltol: £47.60 per 28 days 3
• IV iron: £79.70-£169.50 per 1000 mg elemental iron 3